Trends in Stroke Prevention between 2014 and 2018 in Hospitalized Atrial Fibrillation Patients
In recent years, significant changes in stroke prophylaxis in patients with atrial fibrillation (AF) have been observed. Non-vitamin K antagonist oral anticoagulants (NOACs) are more commonly used in the prevention of thromboembolic complications in patients with AF. The aim of the study was to eval...
Saved in:
Main Authors: | B. Bielecka, I. Gorczyca, O. Jelonek, B. Wożakowska-Kapłon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2021/6657776 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria
by: Yazid Aoudia, et al.
Published: (2017-05-01) -
Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation and Hereditary Hemorrhagic Telangiectasia
by: Sebastiaan Velthuis, et al.
Published: (2012-01-01) -
Detection of Paroxysmal Atrial Fibrillation in Stroke/Tia Patients
by: Muhib Khan, et al.
Published: (2013-01-01) -
Antioxidant Vitamins in the Prevention of Atrial Fibrillation: What Is the Evidence?
by: Sonia Rasoli, et al.
Published: (2011-01-01) -
Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
by: Carlos Rubio-Terrés, et al.
Published: (2016-02-01)